Around the world, IFRA works in partnership with policymakers, regulators and other stakeholders to develop fair and workable regulation that promotes the safe use and enjoyment of fragrance ingredients.
We seek to educate and inform these groups about our business and its needs, to listen to their views, and engage in constructive dialog.
Our four regions and our Regular and National Association members work to develop relations and partnerships with policymakers, regulators and other stakeholders at a local level, with global coordination - an industry speaking with one voice, but many accents.
IFRA Europe has welcomed the European Commission Roadmap on the Chemicals Strategy for Sustainability (CSS).
As the voice of fragrance manufacturers/suppliers in Europe, IFRA Europe is committed to consumer safety and to sustainable development across their many dimensions by continuously looking to create truly sustainable and innovative solutions.
The global fragrance industry is calling on governments to include factories manufacturing fragrance as ‘critical infrastructure’ or ‘essential business’ in combating the current coronavirus (COVID-19) pandemic, and therefore exempt these facilities from measures that would restrict access to employees and close operations.
The global fragrance industry, represented by The International Fragrance Association (IFRA), has issued a statement highlighting the needs being met by the industry during this pandemic, which cannot be done remotely, and which require the day-to-day presence of specialist personnel.
IFRA Europe is among the signatories of a joint letter to the European Commission on digital means and mandatory product information.
IFRA Europe signed the letter with a group of consumer-facing industry sectors, supported by retailers. The letter outlines the opportunities that digitalization can bring to the European Union's citizens and businesses and calls for further action and leadership from the European Commission to make Europe fit for the digital age.
The fragrance industry is fully supportive of and engaged in the pursuit of alternatives to animal testing. We actively help to shape a future in which the safety of people and the protection of the environment can be assured without the use of animal testing.
We are committed to the use of reliable new approach methodologies (NAM) and to foster the technical know-how that would ideally result in the elimination of animal experiments.
IFRA is launching a consortium to prepare an SCCS dossier for Benzyl Salicylate and invites potential participants to express their interest by close of business on Friday 19 June 2020.
This dossier has been requested by the European Commission in the context of suspected endocrine disruptors (EDs) in cosmetic products.